×

CRISPR Therapeutics AG Financial Statements 2014-2024 | CRSP

Annual Data | Millions of US $ except per share data
2024-12-31
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
2018-12-31
2017-12-31
2016-12-31
2015-12-31
$37.314
$371.206
$1.198
$914.963
$0.719
$289.59
$3.124
$40.997
$5.164
$0.247
Cost Of Goods Sold
-
-
-
-
-
-
-
-
-
-
$37.314
$371.206
$1.198
$914.963
$0.719
$289.59
$3.124
$40.997
$5.164
$0.247
$320.653
$387.332
$461.645
$340.567
$266.946
$179.362
$113.773
$69.8
$42.238
$12.573
$72.977
$76.162
$102.464
$99.69
$88.208
$63.488
$48.294
$35.845
$31.056
$13.403
$-110.25
$-130.25
$-110.25
$-101.178
-
-
-
-
-
-
Operating Expenses
-
-
-
-
-
-
-
-
-
-
$-466.566
$-222.538
$-673.161
$373.528
$-354.435
$46.74
$-158.943
$-64.648
$-68.13
$-25.729
$103.901
$71.816
$22.661
$6.003
$6.379
$20.566
$-5.485
$-1.96
$45.412
$-0.092
$-362.665
$-150.722
$-650.5
$379.531
$-348.056
$67.306
$-164.428
$-66.608
$-22.718
$-25.821
$3.587
$2.888
$-0.325
$1.87
$0.809
$0.448
$0.553
$1.749
$0.484
$0.007
$-366.252
$-153.61
$-650.175
$377.661
$-348.865
$66.858
$-164.981
$-68.357
$-23.202
$-25.828
Other Income
-
-
-
-
-
-
-
-
-
-
$-366.252
$-153.61
$-650.175
$377.661
$-348.865
$66.858
$-164.981
$-68.357
$-23.202
$-25.828
Income From Discontinued Operations
-
-
-
-
-
-
-
-
-
-
$-366.252
$-153.61
$-650.175
$377.661
$-348.865
$66.858
$-164.981
$-68.357
$-23.177
$-25.503
$-447.307
$-202.701
$-648.989
$391.481
$-343.394
$51.465
$-155.424
$-61.624
$-67.205
$-25.602
$-466.566
$-222.538
$-673.161
$373.528
$-354.435
$46.74
$-158.943
$-64.648
$-68.13
$-25.729
84
79
78
76
66
54
48
40
12
5
84
79
78
80
66
57
48
40
12
5
$-4.34
$-1.94
$-8.36
$4.97
$-5.29
$1.23
$-3.44
$-1.71
$-1.89
$-5.06
$-4.34
$-1.94
$-8.36
$4.70
$-5.29
$1.17
$-3.44
$-1.71
$-1.89
$-5.06
www.jqwidgets.com